Passengers who travel on American Airlines from September through October 2011 will learn about the surgically implantable bioartificial kidney being developed at UCSF as a permanent solution to end stage renal disease.
Directing this national project and speaking on the airline’s in-flight audio program, Shuvo Roy, PhD...
Michael Fischbach, PhD, who studies drug-like molecules produced by human gut bacteria, has been awarded one the 16 prestigious 2011 Packard Fellowships in Science and Engineering.
The fellowship, which supports “highly creative professors early in their careers,” provides an unrestricted research grant of $875,000 over...
Bo Huang, PhD, a faculty member of the UCSF School of Pharmacy, Department of Pharmaceutical Chemistry, has been named a recipient of a 2011 National Institutes of Health (NIH) Director’s New Innovator Award.
The award, given to 49 new investigators this year, including two other UCSF scientists in the School of...
Pharmaceutical companies will increasingly apply the predictive modeling of quantitative pharmacology to do more efficient drug development, says Kathy Giacomini, PhD, co-chair of the Department of Bioengineering and Therapeutic Sciences (BTS), a joint department of the UCSF Schools of Pharmacy and Medicine, and its new Center...
UCSF Chancellor Susan Desmond-Hellman, MD, MPH, delivered her State of the University address at Cole Hall on the Parnassus campus on October 4, 2011.
In her third year at the helm, Desmond-Hellman presented a renewed mission and vision for the university that included five major goals guiding the health sciences...
Adam Abate, PhD, a faculty member in the UCSF Schools of Pharmacy and Medicine, Department of Bioengineering and Therapeutic Sciences, is a prime trial candidate for QB3’s Startup in a Box.
The program by the UCSF-based California Institute for Quantitative Biosciences aims to help researchers convert ideas and...
An analysis by UCSF faculty members from the Schools of Pharmacy and Medicine has found that the half-dozen most reputable electronic drug information resources—tools commonly used by clinicians to make prescription and patient monitoring decisions—may not provide key elements of some medications’ black box warnings.
Such warnings are...
The new UCSF Center for Quantitative Pharmacology housed within the Department of Bioengineering and Therapeutic Sciences (BTS), a joint department of the Schools of Pharmacy and Medicine, will be inaugurated next week with a wide-ranging, 2-day conference, September 22 and 23, 2011 at William J. Rutter Center on UCSF’s Mission Bay campus....
Louis R. Cantilena, Jr., MD, PhD, is the newly appointed course director of the American Course on Drug Development and Regulatory Sciences (ACDRS) effective summer 2011. This two-year certificate program for pharmaceutical industry professionals is presented by the Department of Bioengineering and Therapeutic Sciences (BTS),...